Market Overview:
The global tumor ablation devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, technological advancements in tumor ablation devices, and rising demand for minimally invasive surgeries. Based on type, the global tumor ablation devices market is segmented into microwave ablation, laser ablation, and ultrasound ablation. Of these segments, the microwave ablations segment is expected to account for the largest share of the global market in 2018. This segment is projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030 owing to its advantages such as high efficacy and low invasiveness as compared with other types of ablations. Based on application, the global tumor ablations device market is divided into urological surgery, gynecological surgery,, general surgery,, gastrointestinal surgery,, and others (including head & neck tumors).
Product Definition:
Tumor ablation devices are medical devices that use energy to destroy tumors. Tumor ablation is a treatment modality used to treat cancer. The destruction of tumors by ablation can be accomplished through the use of thermal, chemical, or radiation means. Thermal tumor ablation uses energy to generate heat and destroy tissue. This type of tumor ablation is accomplished through the use of lasers, microwaves, radiofrequency (RF), ultrasound, or cryotherapy. RF and ultrasound are the most common forms of thermal tumor ablations.
Microwave Ablation:
The global microwave ablation market size was valued at USD 1.6 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The key drivers attributing to its high growth include increasing prevalence of cancer, technological advancements pertaining to minimally invasive surgeries, rising demand for pain-free procedures and cost efficiency as compared with traditional methods.
Laser Ablation:
Laser ablation is a minimally invasive surgical procedure used to treat patients suffering from various types of tumors. The laser beam delivers high-intensity light energy to the tissue and thusly, causes thermal damage or necrosis in the targeted area. Ablation procedures are most commonly used for treating prostate cancer, skin lesions, and gastrointestinal (GI) tract diseases such as Crohn's disease & ulcerative colitis.
U.
Application Insights:
Urological surgery segment dominated the global tumor ablation devices market in 2017 owing to factors such as increasing number of patients suffering from urinary bladder cancer and rising adoption of robotic ureteroscopes for treating these tumors. According to a study published in NCBI, it is estimated that around 14,070 new cases of bladder cancer are expected to be diagnosed in 2019.
The gynecological surgery segment is expected to grow at a lucrative rate during the forecast period due largely on advancements made in ultrasound technology and its application for treating various female reproductive organ disorders. For instance, according to a research study published by National Cancer Center Japan, it was observed that use of Uro-V (a disposable device) resulted in complete ablation of the tumor with minimal complications when compared with conventional open surgeries. This factor is anticipated to fuel market growth over the next few years.
Regional Analysis:
North America dominated the global tumor ablation devices market in 2017. This can be attributed to the presence of well-established healthcare facilities, availability of highly skilled physicians, and high adoption rate for technologically advanced procedures. Moreover, increasing government initiatives to raise awareness regarding oncological diseases is also expected to drive regional growth over the forecast period. For instance, The Cancer Genome Atlas (TCGA) program was launched by the U.S National Cancer Institute (NCI) in 2011 as a collaboration with several other cancer centers across U.S.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for tumor ablation devices market. According to World Health Organization (WHO), in 2012, there were 14 million new cases of cancer and 8.2 million deaths due to cancer worldwide. This number is expected to increase by about 70% over the next two decades, accounting for 21.7 million new cases and 13 million deaths by 2030. This will create a large pool of patients who will require tumor ablation devices for treatment, thereby driving the growth of this market
- Technological advancements: Tumor ablation devices are constantly evolving with technological advancements being made in their design and functionality. These advancements are helping to make these devices more efficient and accurate in their ability to destroy tumors, thereby driving their demand among patients as well as healthcare providers
- Growing preference for minimally invasive procedures: There is a growing preference among patients for minimally invasive procedures over traditional surgery options owing to lower risks associated with them as well as shorter recovery times involved post-procedure . Tumor ablation devices offer an attractive alternative to traditional surgical treatments owing its minimal invasiveness which makes it preferable choice among patients undergoing treatment for tumors
Scope Of The Report
Report Attributes
Report Details
Report Title
Tumor Ablation Devices Market Research Report
By Type
Microwave Ablation, Laser Ablation, Ultrasound Ablation
By Application
Urological Surgery, Gynecological Surgery, General Surgery, Gastrointestinal Surgery, Others
By Companies
Ethicon, Karl Storz, Intuitive Surgical, Medtronic, Olympus, Aesculap, Applied Medical, B. Braun Melsungen, CareFusion, Conmed, Ethicon, Encision, Eon Surgical, Gyrus ACMI, Integra LifeSciences, IMRIS
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Tumor Ablation Devices Market Report Segments:
The global Tumor Ablation Devices market is segmented on the basis of:
Types
Microwave Ablation, Laser Ablation, Ultrasound Ablation
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Urological Surgery, Gynecological Surgery, General Surgery, Gastrointestinal Surgery, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ethicon
- Karl Storz
- Intuitive Surgical
- Medtronic
- Olympus
- Aesculap
- Applied Medical
- B. Braun Melsungen
- CareFusion
- Conmed
- Ethicon
- Encision
- Eon Surgical
- Gyrus ACMI
- Integra LifeSciences
- IMRIS
Highlights of The Tumor Ablation Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Microwave Ablation
- Laser Ablation
- Ultrasound Ablation
- By Application:
- Urological Surgery
- Gynecological Surgery
- General Surgery
- Gastrointestinal Surgery
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tumor Ablation Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tumor ablation devices are medical devices that use heat, electricity, or radiofrequency energy to destroy cancerous tumors.
Some of the major companies in the tumor ablation devices market are Ethicon, Karl Storz, Intuitive Surgical, Medtronic, Olympus, Aesculap, Applied Medical, B. Braun Melsungen, CareFusion, Conmed, Ethicon, Encision, Eon Surgical, Gyrus ACMI, Integra LifeSciences, IMRIS.
The tumor ablation devices market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tumor Ablation Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tumor Ablation Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tumor Ablation Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tumor Ablation Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tumor Ablation Devices Market Size & Forecast, 2018-2028
4.5.1 Tumor Ablation Devices Market Size and Y-o-Y Growth
4.5.2 Tumor Ablation Devices Market Absolute $ Opportunity
Chapter 5 Global Tumor Ablation Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Tumor Ablation Devices Market Size Forecast by Type
5.2.1 Microwave Ablation
5.2.2 Laser Ablation
5.2.3 Ultrasound Ablation
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Tumor Ablation Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Tumor Ablation Devices Market Size Forecast by Applications
6.2.1 Urological Surgery
6.2.2 Gynecological Surgery
6.2.3 General Surgery
6.2.4 Gastrointestinal Surgery
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tumor Ablation Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tumor Ablation Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Tumor Ablation Devices Analysis and Forecast
9.1 Introduction
9.2 North America Tumor Ablation Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Tumor Ablation Devices Market Size Forecast by Type
9.6.1 Microwave Ablation
9.6.2 Laser Ablation
9.6.3 Ultrasound Ablation
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Tumor Ablation Devices Market Size Forecast by Applications
9.10.1 Urological Surgery
9.10.2 Gynecological Surgery
9.10.3 General Surgery
9.10.4 Gastrointestinal Surgery
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Tumor Ablation Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Tumor Ablation Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Tumor Ablation Devices Market Size Forecast by Type
10.6.1 Microwave Ablation
10.6.2 Laser Ablation
10.6.3 Ultrasound Ablation
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Tumor Ablation Devices Market Size Forecast by Applications
10.10.1 Urological Surgery
10.10.2 Gynecological Surgery
10.10.3 General Surgery
10.10.4 Gastrointestinal Surgery
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Tumor Ablation Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Tumor Ablation Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Tumor Ablation Devices Market Size Forecast by Type
11.6.1 Microwave Ablation
11.6.2 Laser Ablation
11.6.3 Ultrasound Ablation
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Tumor Ablation Devices Market Size Forecast by Applications
11.10.1 Urological Surgery
11.10.2 Gynecological Surgery
11.10.3 General Surgery
11.10.4 Gastrointestinal Surgery
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Tumor Ablation Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Tumor Ablation Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Tumor Ablation Devices Market Size Forecast by Type
12.6.1 Microwave Ablation
12.6.2 Laser Ablation
12.6.3 Ultrasound Ablation
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Tumor Ablation Devices Market Size Forecast by Applications
12.10.1 Urological Surgery
12.10.2 Gynecological Surgery
12.10.3 General Surgery
12.10.4 Gastrointestinal Surgery
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Tumor Ablation Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Tumor Ablation Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Tumor Ablation Devices Market Size Forecast by Type
13.6.1 Microwave Ablation
13.6.2 Laser Ablation
13.6.3 Ultrasound Ablation
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Tumor Ablation Devices Market Size Forecast by Applications
13.10.1 Urological Surgery
13.10.2 Gynecological Surgery
13.10.3 General Surgery
13.10.4 Gastrointestinal Surgery
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tumor Ablation Devices Market: Competitive Dashboard
14.2 Global Tumor Ablation Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ethicon
14.3.2 Karl Storz
14.3.3 Intuitive Surgical
14.3.4 Medtronic
14.3.5 Olympus
14.3.6 Aesculap
14.3.7 Applied Medical
14.3.8 B. Braun Melsungen
14.3.9 CareFusion
14.3.10 Conmed
14.3.11 Ethicon
14.3.12 Encision
14.3.13 Eon Surgical
14.3.14 Gyrus ACMI
14.3.15 Integra LifeSciences
14.3.16 IMRIS
